Quick Hits: Moderna Delivers First Potential Coronavirus Vaccine

Clinical trials for the experimental vaccine are expected to start in April.

A recent Time article discussed a new vaccine that could alleviate the coronavirus (aka COVID-19) outbreak. Drugmaker Moderna shipped out the first potential coronavirus vaccine to U.S. government researchers for human testing in record time. The vaccine was developed in just 42 days after the genetic sequence of the virus was released by Chinese researchers. The vaccine is packed with mRNA that codes for the right coronavirus proteins before being injected into the body. Immune cells in the lymph nodes process the mRNA and begin producing the protein in a way that allows other immune cells to identify and mark them to be destroyed.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026